One person in the U.S. state of Georgia died following a multi-state outbreak of melioidosis infection likely linked to imported products, health officials said on Aug. 9.

Aradigm Corp.’s inhaled antibiotic for a rare, incurable disorder affecting the lungs failed a late-stage study, sending the company’s shares down in premarket trading.